Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
glucagon (4 trials)
oxymetazoline (ocuclear) (1 trial)
Common Cold (Phase 1)
Diabetes Mellitus (Phase 1)
Diabetes Mellitus, Type 1 (Phase 1)
Diabetes Mellitus, Type 2 (Phase 1)
Trials (4 total)
Trial APIs (2 total)